Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Phosphodiesterase 4 Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
APREMILAST 136,713 4,704 3.4% 9,544 3,389 54.0 yrs 67.3%
CRISABOROLE 7,784 22 0.3% 53 1 39.7 yrs 65.9%
ROFLUMILAST 2,700 645 23.9% 625 76 68.8 yrs 56.3%
ENSIFENTRINE 410 2 0.5% 77 7 71.7 yrs 51.6%

Head-to-Head Comparisons

APREMILAST vs CRISABOROLE APREMILAST vs ROFLUMILAST APREMILAST vs ENSIFENTRINE CRISABOROLE vs ROFLUMILAST CRISABOROLE vs ENSIFENTRINE ROFLUMILAST vs ENSIFENTRINE
← Back to Phosphodiesterase 4 Inhibitor [EPC] Class side effects →